Synapse - Nursing

Results (178)

Preoperative and postoperative nursing considerations for the oncoplastic and reconstructive patient

Book Section

Lagdamen, L. L.; Benitez, M. O.; Fox, J.; Fitzpatrick, M.
In Urban, C.; Rietjens, M.; El-Tamer, M.; Sacchini, V. S. (Eds.) Oncoplastic and Reconstructive Breast Surgery. 2nd ed (2019)

Fulltext@MSK | Save

Anesthesia for orthognathic surgery and rhinoplasty

Book Section

Galante, L.; Angus, H.; Rosenblatt, W.
In Steinbacher, D. M. (Eds.) Aesthetic Orthognathic Surgery and Rhinoplasty (2019)

Fulltext@MSK | Save

Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: A phase II study

Meeting Abstract

Rampal, R. K.; Verstovsek, S.; Devlin, S. M.; King, A. C.; Stein, E. M.; Pemmaraju, N.; Mauro, M. J.; Kadia, T. M.; Montalban-Bravo, G.; Alvarez, K.; more...
Blood (2019)

Fulltext@MSK | Save

Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management

Meeting Abstract

Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
Blood (2019)

Fulltext@MSK | Save

First line chemo-free therapy with the BRAF inhibitor vemurafenib combined with obinutuzumab is effective in patients with HCL

Meeting Abstract

Park, J. H.; Shukla, M.; Salcedo, J. M.; Vemuri, S.; Kinoshita, J. C.; Smith, M. D.; Winer, E. S.; Abdel-Wahab, O.; Tallman, M. S.
Blood (2019)

Fulltext@MSK | Save

EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells

Meeting Abstract

Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL

Meeting Abstract

Park, J. H.; Flynn, J.; Gonen, M.; Bernal, Y.; Diamonte, C.; Halton, E.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
Blood (2019)

Fulltext@MSK | Save

Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma

Meeting Abstract

Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
Blood (2019)

Fulltext@MSK | Save

Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
Blood (2019)

Fulltext@MSK | Save

A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
Blood (2019)

Fulltext@MSK | Save